Recent Articles

November 15, 2016 8:31 am
Dusty Tenney, President, Brooks Life Science Systems
A comprehensive sample lifecycle management plan provides detail on where and who will manage samples, as well as what resources will be required.
November 15, 2016 1:47 pm
Ryan Bushey
Amgen announced good news for its cholesterol drug Repatha at the annual American Heart Association meeting taking place in New Orleans.
November 14, 2016 8:29 am
Ryan Bushey
Drug makers are working with companies like Propeller Health on these devices because they could provide improved adherence and better health outcomes.
November 10, 2016 9:54 am
Ryan Bushey
The biotech company will pay $100 million upfront to Japan’s Nitto Denko who developed this drug.
November 10, 2016 11:00 am
Christos Michaelides, Ph.D., Neurology and Opthamology Analyst, GlobalData
ALKS-5461 was granted fast track designation by the FDA for the adjunctive treatment of MDD in patients with an inadequate response to standard antidepressant therapies.
November 9, 2016 8:00 am
Ryan Bushey
Roche’s cancer drug business could soon face some competition.
November 8, 2016 9:53 am
Ryan Bushey
Currently, there are no approved drugs for spinal muscular atrophy.
November 8, 2016 9:51 am
Tim Hoctor, Vice President, Corporate R&D Professional Services, Elsevier
The pharma industry is under increasing pressure to find ways of treating rare diseases since, currently, there is no approved drug treatment for 95 percent of them.
November 4, 2016 1:45 pm
Ryan Bushey
Nestle’s health science unit is expanding its presence in the biotech space with a new investment.
November 4, 2016 8:34 am
Ryan Bushey
One of the world’s largest food and beverage companies is launching a new initiative to help children all over the world.
Subscribe to Drug Discovery & Development